| 发明名称 |
METHOD OF DETERMINING THE RISK OF BREAST CANCER DEVELOPMENT |
| 摘要 |
This invention relates to a method of determining, in a subject having active breast gross cystic disease, the risk of future breast cancer development. The level of glycoprotein GCDFP-15 in the plasma is measured at the time of cyst aspiration in order to provide an indication as to the likehood of future breast cancer development.
|
| 申请公布号 |
WO9707397(A1) |
申请公布日期 |
1997.02.27 |
| 申请号 |
WO1996US12949 |
申请日期 |
1996.08.08 |
| 申请人 |
SIGNET LABORATORIES, INC. |
发明人 |
HAAGENSEN, DARROW, E., JR. |
| 分类号 |
G01N33/50;G01N33/574;(IPC1-7):G01N33/53 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
